Time-dependent effects of BRAF-V600E on cell cycling, metabolism, and function in engineered myocardium

Candidate cardiomyocyte (CM) mitogens such as those affecting the extracellular signal-regulated kinase (ERK) signaling pathway represent potential targets for functional heart regeneration. We explored whether activating ERK via a constitutively active mutant of B-raf proto-oncogene (BRAF), BRAF-V600E (caBRAF), can induce proproliferative effects in neonatal rat engineered cardiac tissues (ECTs). Sustained CM-specific caBRAF expression induced chronic ERK activation, substantial tissue growth, deficit in sarcomeres and contractile function, and tissue stiffening, all of which persisted for at least 4 weeks of culture. caBRAF-expressing CMs in ECTs exhibited broad transcriptomic changes, shift to glycolytic metabolism, loss of connexin-43, and a promigratory phenotype. Transient, doxycycline-controlled caBRAF expression revealed that the induction of CM cycling is rapid and precedes functional decline, and the effects are reversible only with short-lived ERK activation. Together, direct activation of the BRAF kinase is sufficient to modulate CM cycling and functional phenotype, offering mechanistic insights into roles of ERK signaling in the context of cardiac development and regeneration.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:10

Enthalten in:

Science advances - 10(2024), 4 vom: 26. Jan., Seite eadh2598

Sprache:

Englisch

Beteiligte Personen:

Strash, Nicholas [VerfasserIn]
DeLuca, Sophia [VerfasserIn]
Janer Carattini, Geovanni L [VerfasserIn]
Chen, Yifan [VerfasserIn]
Wu, Tianyu [VerfasserIn]
Helfer, Abbigail [VerfasserIn]
Scherba, Jacob [VerfasserIn]
Wang, Isabella [VerfasserIn]
Jain, Mehul [VerfasserIn]
Naseri, Ramona [VerfasserIn]
Bursac, Nenad [VerfasserIn]

Links:

Volltext

Themen:

EC 2.7.11.1
EC 2.7.11.24
Extracellular Signal-Regulated MAP Kinases
Journal Article
Proto-Oncogene Proteins B-raf

Anmerkungen:

Date Completed 26.01.2024

Date Revised 01.02.2024

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1126/sciadv.adh2598

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM367565218